Completed PHASE3 INTERVENTIONAL 2-arm NCT00293761

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Sponsor: Alcon Research

Conditions Ocular Hypertension Open-angle Glaucoma

Interventions Travoprost (TRAVATAN) Travoprost, Investigational

Updated 7 times since 2017 Last updated: Nov 17, 2016 Started: Jan 31, 2006 Primary completion: May 31, 2006 Completion: May 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Ocular Hypertension and Open-angle Glaucoma, this trial is completed. The trial is conducted by Alcon Research and has accumulated 7 data snapshots since 2006. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Jan 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alcon Research

Data source: Alcon Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.